Last reviewed · How we verify

NCT04187638

Effect of Olive Oil Consumption on Cardiovascular Biomarkers

Status unknown NA Last updated 17 March 2020
What this trial tests

NA trial testing Olive oil in Cardiovascular Risk Factor in 30 participants. Status unknown.

Timeline
31 January 2019
Primary endpoint
31 December 2019
1 August 2020

Quick facts

Lead sponsorNorthumbria University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment30
Start date31 January 2019
Primary completion31 December 2019
Estimated completion1 August 2020
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Northumbria University

Who can join

Adults 18 to 70, male only, with Cardiovascular Risk Factor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim of this study is to examine the effect of olive oil consumption on several cardiovascular risk markers between Caucasians and Asian ethnicity. The primary assessments: endothelial function's biomarkers: cell and vascular adhesion molecules (ICAMs and VCAMs) and nitric oxide (NO). The secondary assessments: Lipid profile.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effects of extra virgin olive oil or butter on cardiovascular biomarkers in European and Chinese males in the UK: A pilot randomised crossover trial.
    Liang F, Young J, Koutsidis G, Lara Gallegos J. · · 2025 · PMID 37461824 · DOI 10.1177/02601060231187516

Verify or expand the search:

Other trials of Olive oil

Trials testing the same drug.

Other recruiting trials for Cardiovascular Risk Factor

Currently open trials in the same condition.

Other Northumbria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04187638.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing